Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#HealthcareResearch

Home » #HealthcareResearch
CID’s Most-Read Article: “Miracle Drug” Metformin Significantly Reduces Viral Load in Outpatient COVID-19 Patients!

CID’s Most-Read Article: “Miracle Drug” Metformin Significantly Reduces Viral Load in Outpatient COVID-19 Patients!

Posted by By Mourabit Halima 2024.09.11
Editor's Note: Metformin, often hailed as a "miracle drug" for its wide range of therapeutic effects, was also considered a potential treatment for COVID-19 during the pandemic. Unfortunately, the large-scale…
Read More
JHEP | MASLD Without Cirrhosis Still Poses High Liver Cancer Risk, Presenting Challenges for Clinical Management

JHEP | MASLD Without Cirrhosis Still Poses High Liver Cancer Risk, Presenting Challenges for Clinical Management

Posted by By El Bachir MOURABIT 2024.09.10
Editor's Note: Metabolic-associated steatotic liver disease (MASLD) has become the fastest-growing cause of hepatocellular carcinoma (HCC). A recent multicenter clinical study led by Dr. Carole Vitellius from Angers University Hospital,…
Read More
AASLD Hot Updates on MASLD from the 2023 Annual Meeting

AASLD Hot Updates on MASLD from the 2023 Annual Meeting

Posted by By Kenzy Nour 2024.01.16
Editor's Note: On November 7, 2023, at 12:30 PM local time in Boston, the American Association for the Study of Liver Diseases (AASLD) held its sole pre-conference press briefing on…
Read More
Recent Posts
  • Prof. Liang Huang: From “One-Size-Fits-All” to “Tailored Treatment” — De-escalation and Advancement in Individualized Surgical Management of Breast Cancer | 2026 Lingnan Breast Cancer Academic Forum
  • 23rd World Breast Health Congress丨Prof. Jin Zhang: China’s Breast Cancer Care Has Transitioned from Following to Leading, with Whole-Life-Cycle Management Experience Benefiting the World
  • 23rd World Breast Health Congress丨Prof. Jian Yin: Building on Local Practice to Advance the Standardization and Internationalization of Oncoplastic Breast Surgery
  • 23rd World Breast Health Congress丨Prof. Ying Wang: Deepening International Collaboration to Promote Equitable Development of Breast Health in China
  • Sadia Khan: Insights from US Training in Oncoplastic Breast-Conserving Surgery丨2026 Beijing Breast Cancer Forum
Recent Comments
    Archives
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top